# Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

> **NCT04915287** · PHASE4 · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 476 (estimated)

## Conditions studied

- Thrombocytopenia; Drugs
- Chronic Liver Disease

## Interventions

- **DRUG:** Avatrombopag maleate
- **BIOLOGICAL:** Platelet transfusion
- **DRUG:** Medicine

## Key facts

- **NCT ID:** NCT04915287
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-06
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-07-31
- **Target enrollment:** 476 (ESTIMATED)
- **Last updated:** 2022-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04915287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04915287, "Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04915287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*